70 related articles for article (PubMed ID: 31158876)
1. Would You Recommend Prostate-Specific Antigen Screening for This Patient?: Grand Rounds Discussion From Beth Israel Deaconess Medical Center.
Burns RB; Olumi AF; Owens DK; Smetana GW
Ann Intern Med; 2019 Jun; 170(11):770-778. PubMed ID: 31158876
[TBL] [Abstract][Full Text] [Related]
2. Comparative effectiveness of alternative prostate-specific antigen--based prostate cancer screening strategies: model estimates of potential benefits and harms.
Gulati R; Gore JL; Etzioni R
Ann Intern Med; 2013 Feb; 158(3):145-53. PubMed ID: 23381039
[TBL] [Abstract][Full Text] [Related]
3. The Memorial Sloan Kettering Cancer Center Recommendations for Prostate Cancer Screening.
Vickers AJ; Eastham JA; Scardino PT; Lilja H
Urology; 2016 May; 91():12-8. PubMed ID: 26850815
[TBL] [Abstract][Full Text] [Related]
4. Does shared decision making increase prostate screening uptake in countries with a low prevalence of prostate cancer?
Amin HS; Arafa MA; Farhat KH; Rabah DM; Altaweel AA; Alhammad AH
Afr Health Sci; 2020 Dec; 20(4):1870-1874. PubMed ID: 34394251
[TBL] [Abstract][Full Text] [Related]
5. Society of Behavior Medicine (SBM) Urges Congress to Ensure Affordable Care Act Coverage of Prostate Cancer Screening Support Services for High-Risk Men.
Watson K; Buscemi J; Fitzgibbon M; Murray M; Murphy A; Abern M; Gann P; Levi JB; Stinson J; Diefenbach M; Winn RA
Transl Behav Med; 2020 May; 10(2):492-494. PubMed ID: 30855080
[TBL] [Abstract][Full Text] [Related]
6. Medical center characteristics associated with PSA screening in elderly veterans with limited life expectancy.
So C; Kirby KA; Mehta K; Hoffman RM; Powell AA; Freedland SJ; Sirovich B; Yano EM; Walter LC
J Gen Intern Med; 2012 Jun; 27(6):653-60. PubMed ID: 22180196
[TBL] [Abstract][Full Text] [Related]
7. Screening for prostate cancer with prostate-specific antigen testing: American Society of Clinical Oncology Provisional Clinical Opinion.
Basch E; Oliver TK; Vickers A; Thompson I; Kantoff P; Parnes H; Loblaw DA; Roth B; Williams J; Nam RK
J Clin Oncol; 2012 Aug; 30(24):3020-5. PubMed ID: 22802323
[TBL] [Abstract][Full Text] [Related]
8. The evaluation of two methods to facilitate shared decision making for men considering the prostate-specific antigen test.
Frosch DL; Kaplan RM; Felitti V
J Gen Intern Med; 2001 Jun; 16(6):391-8. PubMed ID: 11422636
[TBL] [Abstract][Full Text] [Related]
9. Reactions to Recommendations and Evidence About Prostate Cancer Screening Among White and Black Male Veterans.
Danan ER; White KM; Wilt TJ; Partin MR
Am J Mens Health; 2021; 15(3):15579883211022110. PubMed ID: 34096377
[TBL] [Abstract][Full Text] [Related]
10. Factors influencing Nigerian men's decision to undergo prostate specific antigen testing.
Enaworu OU; Khutan R
Afr Health Sci; 2016 Jun; 16(2):524-32. PubMed ID: 27605968
[TBL] [Abstract][Full Text] [Related]
11. Reducing PSA-Based Prostate Cancer Screening in Men Aged 75 Years and Older with the Use of Highly Specific Computerized Clinical Decision Support.
Shelton JB; Ochotorena L; Bennett C; Shekelle P; Kwan L; Skolarus T; Goldzweig C
J Gen Intern Med; 2015 Aug; 30(8):1133-9. PubMed ID: 25740462
[TBL] [Abstract][Full Text] [Related]
12. Would You Screen This Patient for Cognitive Impairment? : Grand Rounds Discussion From Beth Israel Deaconess Medical Center.
Burns RB; Barry MJ; Blacker D; Kanjee Z
Ann Intern Med; 2023 Oct; 176(10):1405-1412. PubMed ID: 37812780
[TBL] [Abstract][Full Text] [Related]
13. Race-Specific Trends in Prostate Cancer Screening and Presentation before and after the 2012 United States Preventive Services Task Force Statement.
Horton B; Alexeeff S; Prausnitz S; Avins AL; Presti J
Urol Pract; 2022 Jan; 9(1):64-71. PubMed ID: 37145559
[TBL] [Abstract][Full Text] [Related]
14. The routine use of prostate-specific antigen for early detection of cancer prostate in India: Is it justified?
Dubey D
Indian J Urol; 2009 Apr; 25(2):177-84. PubMed ID: 19672341
[TBL] [Abstract][Full Text] [Related]
15. Impact of the US Preventive Services Task Force Grade D Recommendation: Assessment of Evaluations for Elevated Prostate-specific Antigen and Prostate Biopsies in a Large Urology Group Practice Following Statement Revision.
McGinley KF; McMahon GC; Brown GA
Rev Urol; 2015; 17(3):171-7. PubMed ID: 26543432
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer screening-when to start and how to screen?
Kohestani K; Chilov M; Carlsson SV
Transl Androl Urol; 2018 Feb; 7(1):34-45. PubMed ID: 29594018
[TBL] [Abstract][Full Text] [Related]
17. Screening for prostate cancer: the debate continues.
Matrana MR; Atkinson B
J Adv Pract Oncol; 2013 Jan; 4(1):16-21. PubMed ID: 25031977
[TBL] [Abstract][Full Text] [Related]
18. A new approach to prostate cancer screening.
Filella X; González Á; Augé JM; Barco A; Carbonell R; Gaspar MJ; Martínez-Peinado A; Barrios CP; Sánchez-Carbayo M; Santotoribio JD; Trapé J;
Adv Lab Med; 2023 Sep; 4(3):207-211. PubMed ID: 38075179
[TBL] [Abstract][Full Text] [Related]
19. USPSTF and FDA: PSA and 5ARIs.
Klotz LH
Can Urol Assoc J; 2011 Dec; 5(6):373-4. PubMed ID: 22154624
[No Abstract] [Full Text] [Related]
20. [
Hofman MS; Emmett L; Sandhu S; Iravani A; Joshua AM; Goh JC; Pattison DA; Tan TH; Kirkwood ID; Ng S; Francis RJ; Gedye C; Rutherford NK; Weickhardt A; Scott AM; Lee ST; Kwan EM; Azad AA; Ramdave S; Redfern AD; Macdonald W; Guminski A; Hsiao E; Chua W; Lin P; Zhang AY; McJannett MM; Stockler MR; Violet JA; Williams SG; Martin AJ; Davis ID;
Lancet; 2021 Feb; 397(10276):797-804. PubMed ID: 33581798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
